Meeting report: The 11th international conference on differentiation therapy and innovative therapeutics in oncology

Cancer Research

Volumn 67, Issue 22, 2007, Pages 10635-10637

  Delva, Laurent ^a   Zelent, Arthur ^b   Naoe, Tomoki ^c   Fenaux, Pierre ^d   Waxman, Samuel ^e   Degos, Laurent ^f   Chomienne, Christine ^f  

^a UNIVERSITÉ DE BOURGOGNE   (France)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^c NAGOYA UNIVERSITY   (Japan)

^d AVICENNE HOSPITAL   (France)

^e MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^f INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; ANTINEOPLASTIC AGENT; ARSENIC TRIOXIDE; AZACITIDINE; ERYTHROPOIETIN; IMATINIB; INTERLEUKIN 2; IPH 1101; PHOSPHOTRANSFERASE INHIBITOR; RETINOIC ACID; RETINOID; RETINOID DERIVATIVE; RETINOID X RECEPTOR; UNCLASSIFIED DRUG; VORINOSTAT;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; CANCER; CANCER MODEL; CANCER PREVENTION; CANCER RESEARCH; CANCER THERAPY; CLINICAL PRACTICE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; DRUG ACTIVITY; EPIGENETICS; EXPERIMENTAL THERAPY; HUMAN; IMMUNOTHERAPY; LOW DRUG DOSE; MEDICAL PRACTICE; MYELODYSPLASTIC SYNDROME; MYELOID LEUKEMIA; NONHUMAN; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA;

ANIMALS; APOPTOSIS; CELL DIFFERENTIATION; EPIGENESIS, GENETIC; HUMANS; IMMUNOTHERAPY; LEUKEMIA; MEDICAL ONCOLOGY; MICE; NEOPLASMS; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC;

EID: 36348957489     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-07-1152     Document Type: Conference Paper

References (1)

1. Zelent A, Petrie K, Chen Z, et al. Molecular target-based treatment of human cancer: summary of the 10th International Conference on Differentiation Therapy. Cancer Res 2005;65:1117-23.